AlphaYou
Overview
Key stats
Fundamentals Sep 10- Open
- $75.08
- 52-wk high
- $147.22
- High
- $75.84
- 52-wk low
- $70.98
- Low
- $74.83
- Prev close
- $73.31
- Mkt cap
- $30.29B
- P/E
- 12.0x
- Volume
- 4.17M
- Fwd P/E
- 12.3x
- Beta
- 0.73
- Div yield
- 2.80%
- P/S
- 3.2x
- P/B
- 9.7x
- Profit margin
- +27.7%
- Op margin
- +40.7%
- ROE
- +64.9%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsSmart money
8 funds hold a position, insiders have been net buying, and 1 fin-fluencer is discussing it.
What funds are doing
Activist stakes, short interest & more
Earnings
Earnings came in 1.6% above what analysts expected.
Earnings per share
$1.84 expected
Revenue
$2.51B expected
GAAP EPS was $1.65 and adjusted EPS was $1.87. The adjusted figure is comparable to consensus.
Full Year 2026 guidance
$9.12B to $9.32B
No comparable estimate
Reports Nov 3, 2026, in 54 days
EPS expected
$1.44 to $1.60
Revenue expected
12 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
What the company said
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $2.40B | $2.39B | $2.26B | $2.47B |
| Cost of what it sold | $715.0M | $743.0M | $641.0M | $673.0M |
| Gross profit | $1.69B | $1.64B | $1.62B | $1.79B |
| What it spent | ||||
| Research and development | $170.0M | $199.0M | $180.0M | $173.0M |
| Sales and admin | $579.0M | $619.0M | $588.0M | $592.0M |
| Other operating costs | — | — | $31.0M | $93.0M |
| Total operating expenses | $749.0M | $818.0M | $799.0M | $858.0M |
| What was left | ||||
| Operating profit | $936.0M | $826.0M | $822.0M | $937.0M |
| Interest on debt | $64.0M | $57.0M | $62.0M | $61.0M |
| Profit before tax | $887.0M | $761.0M | $758.0M | $866.0M |
| Tax | $166.0M | $158.0M | $157.0M | $175.0M |
| Net profit | $721.0M | $603.0M | $601.0M | $691.0M |
| EBITDA | $1.07B | $939.0M | $939.0M | $927.0M |
Technicals
Price structure
This stock's price action is mixed.
Trend
Mixed
55 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage leans bearish
Tone of tracked coverage
DAQO New Energy Corp. (NYSE:DQ) Given Average Recommendation of "Reduce" by Brokerages
NeutralSep 4Gilead Sciences (NASDAQ:GILD) CEO Sells 15,000 Shares of Stock
Leans bullishSep 2Zoetis to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
NeutralSep 2Zoetis Inc. Class A (ZTS) Shareholding Pattern – Promoters, FIIs & DIIs
NeutralAug 28JATT mastermind launches latest biotech-focused SPAC in $60M IPO
NeutralAug 26BlackRock Inc. Makes New Investment in Sunstone Hotel Investors, Inc. $SHO
NeutralAug 26ZTS Maintained by TD Cowen -- Price Target Lowered to $94.00
Leans bearishAug 25TD Cowen cuts Zoetis stock price target on clinic visit declines
BearishAug 25
Macro
31 macro signals shaping ZTS right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results